#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15094	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2121	706.5	0	.	n	.	0	A69G	SNP	69	69	A	279	279	G	852	G,T	785,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15094	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2121	706.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1660	1660	T	855	T,C	791,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15094	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2121	706.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1394	1394	C	909	C	857	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27990	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3591	777.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1655	1655	A	955	A	893	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27990	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3591	777.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2289	2289	C	921	C	853	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27990	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3591	777.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2363	2363	A	930	A	882	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27990	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3591	777.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2915	2915	C	879	C,T	803,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27990	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3591	777.3	0	HET	.	.	.	G2209A,T,C	.	2209	2209	G	2527	2527	G	845	G,A,T,C	620,165,1,1	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2062	folP	852	852	99.88	folP.l15.c4.ctg.1	1550	132.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	801	803	AAA	212;213;215	A;A;A	196;199;200	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2062	folP	852	852	99.88	folP.l15.c4.ctg.1	1550	132.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1032	1034	AGC	176;177;180	A;G,C;C	170;170,1;172	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5298	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3383	156.1	0	.	p	.	0	G479S	NONSYN	1435	1437	GGC	1743	1745	AGC	192;189;187	A;G;C	180;179;175	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5298	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3383	156.1	0	.	p	.	0	R626C	NONSYN	1876	1878	CGC	2184	2186	TGC	175;175;177	T;G;C	162;164;165	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5298	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3383	156.1	1	SNP	p	S91F	0	.	.	271	273	TCC	579	581	TCC	213;214;214	T,C;C;C	196,1;196;197	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5298	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3383	156.1	1	SNP	p	D95G	0	.	.	283	285	GAC	591	593	GAC	214;209;207	G;A;C	199;196;194	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5298	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3383	156.1	1	SNP	p	D95N	0	.	.	283	285	GAC	591	593	GAC	214;209;207	G;A;C	199;196;194	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1796	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1388	129.1	1	SNP	p	G45D	0	.	.	133	135	GGC	536	538	GGC	227;223;223	G;G;C	205;201;203	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	826	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	950	86.7	0	.	n	.	0	A197.	DEL	197	197	A	532	532	A	198	A,C	185,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5036	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2913	172.3	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1630	1632	GCA	216;217;220	G;C,T;A,G	196;192,1;189,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5036	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2913	172.3	1	SNP	p	D86N	0	.	.	256	258	GAC	583	585	GAC	201;203;205	G;A;C	185;184;189	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5036	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2913	172.3	1	SNP	p	S87W	0	.	.	259	261	AGT	586	588	AGT	204;205;205	A;G;T	187;189;184	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5036	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2913	172.3	1	SNP	p	S87R	0	.	.	259	261	AGT	586	588	AGT	204;205;205	A;G;T	187;189;184	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5036	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2913	172.3	1	SNP	p	S87I	0	.	.	259	261	AGT	586	588	AGT	204;205;205	A;G;T	187;189;184	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5036	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2913	172.3	1	SNP	p	S88P	0	.	.	262	264	TCC	589	591	TCC	206;206;203	T;C;C	188;187;187	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4492	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2537	176.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1482	1484	GGC	223;225;226	G;G;C	209;208;209	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1306	1308	GCA	188;189;189	G;C;A	172;173;174	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1309	1311	ATC	187;186;186	A;T;C	174;172;172	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1321	1323	GTG	198;199;202	G;T;G,A	180;180;179,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1321	1323	GTG	198;199;202	G;T;G,A	180;180;179,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1825	1827	ACC	203;202;201	A;C;C	181;183;184	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1879	1881	GCG	201;201;202	G;C;G	176;164;170	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1879	1881	GCG	201;201;202	G;C;G	176;164;170	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2002	2004	GGC	176;173;174	G;G,T;C	165;161,1;163	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2011	2013	GGC	169;167;169	G;G;C	158;158;160	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4076	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2432	167.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2029	2031	CTG	167;170;169	C,G;TG,TGG;G	129,2;132,1;136	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6158	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3083	199.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1605	1607	CCG	243;241;238	C;C;G	218;227;218	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2312	porA	1146	1146	99.65	porA.l6.c17.ctg.1	2023	113.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	651	651	C	150	C	141	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2966	porB1b	1035	1035	97.23	porB1b.l15.c17.ctg.1	1629	181.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	580	582	GGA	242;242;242	G;G;A	224;223;223	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2966	porB1b	1035	1035	97.23	porB1b.l15.c17.ctg.1	1629	181.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	703	705	AGC	219;215;217	A;G,C;C	206;201,1;205	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2966	porB1b	1035	1035	97.23	porB1b.l15.c17.ctg.1	1629	181.5	0	.	p	.	0	V98I	NONSYN	292	294	GTC	730	732	ATC	220;220;218	A;T;C	205;204;202	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2966	porB1b	1035	1035	97.23	porB1b.l15.c17.ctg.1	1629	181.5	0	.	p	.	0	V109A	NONSYN	325	327	GTC	763	765	GCC	235;233;236	G;C;C	206;208;215	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2966	porB1b	1035	1035	97.23	porB1b.l15.c17.ctg.1	1629	181.5	0	.	p	.	0	A121S	NONSYN	361	363	GCC	799	801	AGC	246;247;247	A;G;C	231;229;228	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2966	porB1b	1035	1035	97.23	porB1b.l15.c17.ctg.1	1629	181.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	802	804	AAA	242;240;240	A;A;A	226;226;225	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2966	porB1b	1035	1035	97.23	porB1b.l15.c17.ctg.1	1629	181.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	841	843	CTT	226;228;226	C;T;T	202;206;205	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2966	porB1b	1035	1035	97.23	porB1b.l15.c17.ctg.1	1629	181.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1069	1069	T	268	T	249	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11506	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4764	240.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1956	1958	CAT	241;241;242	C;A;T	232;230;233	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1278	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	888	141.8	1	SNP	p	V57M	1	.	.	169	171	ATG	437	439	ATG	281;278;278	A;T;G	266;262;263	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
